Literature DB >> 27703467

Modifiable Factors Associated with Cognitive Impairment in 1,143 Japanese Outpatients: The Project in Sado for Total Health (PROST).

Kaori Kitamura1, Yumi Watanabe1, Kazutoshi Nakamura1, Kazuhiro Sanpei2, Minako Wakasugi3, Akio Yokoseki4, Osamu Onodera4, Takeshi Ikeuchi5, Ryozo Kuwano5, Takeshi Momotsu2, Ichiei Narita6, Naoto Endo7.   

Abstract

BACKGROUND/AIMS: Evidence on modifiable factors associated with cognitive impairment in Japanese patients is scarce. This study aimed to determine modifiable factors for cognitive impairment in a Japanese hospital-based population.
METHODS: Subjects of this cross-sectional study were 1,143 patients of Sado General Hospital (Niigata, Japan) registered in the Project in Sado for Total Health (PROST) between June 2008 and September 2014. We assessed disease history, body mass index (BMI), leisure time physical activity, walking time, smoking and drinking habits, and consumption of vegetables, fruits, and green tea as predictors, with cognitive impairment defined by the Mini-Mental State Examination (score <24) as an outcome. Multiple logistic regression analysis was performed to calculate odds ratios (ORs) for cognitive impairment.
RESULTS: The mean subject age was 68.9 years, and the prevalence of cognitive impairment was 21.5%. Multivariate analysis revealed that age (p < 0.001), low BMI (<21.1; OR 1.39, 95% CI 1.12-1.72), a history of stroke (p = 0.003), a history of myocardial infarction (p = 0.038), low fruit consumption (p for trend = 0.012), and low green tea consumption (p for trend = 0.032) were independently associated with a higher prevalence of cognitive impairment.
CONCLUSIONS: Modifiable factors, such as low BMI, low fruit consumption, and low green tea consumption, are associated with cognitive impairment. Longitudinal studies will be needed to confirm these findings.

Entities:  

Keywords:  Aged; Body mass index; Cognition; Cross-sectional study; Dementia; Epidemiology; Mini-Mental State Examination

Year:  2016        PMID: 27703467      PMCID: PMC5040930          DOI: 10.1159/000447963

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Dis Extra        ISSN: 1664-5464


Introduction

Growing numbers of dementia patients have become an important public health issue worldwide. Currently, approximately 36 million people are affected by dementia globally, and the number is projected to triple by 2050 [1]. An increasing number of dementia patients also represent a major public health burden in Japan, where the elderly population is rapidly growing. The number of dementia patients in Japan was estimated to be 2.8 million in 2010 and is expected to reach 4.7 million in 2025 [2]. Dementia reduces the quality of life of both patients and their families who provide care and causes social and economic loss due to increased medical care costs. As effective treatments for dementia are limited, prevention is a focus of attention. Modifiable factors associated with cognition and dementia should be determined in view of dementia prevention, and in this context, a number of epidemiological studies have been conducted [3]. A review by Beydoun et al. [3] found lower educational attainment and decreased physical activity to be major predictors, but further studies will be needed to identify other potential modifiable factors in various ethnic groups. Epidemiological studies conducted in Japan have been scarce, with only a few articles mentioned in recent reviews [3,4], although some studies targeting Japanese populations have recently been published [5,6]. Cognitive impairment appears in the early or intermediate stage of dementia and is thus targeted in the prevention of this disorder. It is also a meaningful outcome in epidemiological studies, given that cognitive impairment in early stages of dementia is not only a high risk factor for dementia but also an important risk factor for frailty [7], which potentially leads to increased care costs [8]. Against this backdrop, this study aimed to determine modifiable factors for cognitive impairment in a Japanese hospital-based population that underwent a cognitive function examination.

Subjects and Methods

Subjects

The subjects of the present cross-sectional study were those registered in the patient registry of Sado General Hospital in Sado City, Sado Island, Japan (population of 64,310 as of October 1, 2008; working populations of 24% for primary, 21% for secondary, and 54% for tertiary industries, and per capita income of 2.0 million JPY [9]), during the period between June 2008 and September 2014. Sado Island is located 30 km off the coast of Niigata City (population of approximately 800,000; working populations of 5% for primary, 23% for secondary, and 72% for tertiary industries, and per capita income of 2.8 million JPY [9]), the capital of Niigata Prefecture, in mainland Japan. This registry, referred to as the Project in Sado for Total Health (PROST), was initiated in June 2008 in conjunction with the Center for Inter-Organ Communication Research, Niigata University Graduate School of Medical and Dental Sciences, and included all outpatients aged 20 years and older. Details regarding PROST have been described elsewhere [10]. Upon registration, cognitive function and blood pressure were examined, and demographic and lifestyle information was collected. For the present study, the inclusion criterion was patients aged 40 years or older, excluding those undergoing kidney dialysis, which is considered an independent predictor of cognitive impairment [11]. As of September 11, 2014, a total of 2,161 patients were registered, of whom 1,240 underwent a cognitive function examination. Of these, 97 undergoing dialysis were excluded, and the remaining 1,143 patients were considered the subjects of this study.

Measurements

Cognitive function was assessed using the Mini-Mental State Examination (MMSE) [12], a brief, validated instrument commonly used to screen for dementia. MMSE scores range from 0 to 30, with lower scores indicating greater cognitive impairment. The area under the receiver operating characteristic curve of MMSE for DSM-III-R-diagnosed dementia in a Japanese population was reported to be as high as 0.980 [13]. Cognitive impairment was defined as an MMSE score of <24 (i.e. MMSE cutoff score of 23/24) [13,14]. Systolic and diastolic blood pressures were measured twice using an automatic sphygmomanometer after an at least 5-min rest. Body weight and height were measured with a digital scale. Height was estimated as twice the value of the arm span [15] for patients whose height was not measured using the scale. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m2). Information on sex, age, disease history, physical activity, smoking and drinking habits, and frequency of vegetable, fruit, and green tea consumption was obtained using a questionnaire. The current history of hypertension and diabetes and the past history of stroke and heart disease were taken. Walking time was indicated as none, 1-29, 30-59, or ≥60 min/day and leisure time physical activity (exercise, brisk walk, etc.) as none, 1-2, 3-4, or ≥5 times/week. For smoking habit, patients were classified as nonsmoker, past smoker, and current smoker and for alcohol intake as nondrinker, chance drinker, and drinker (at least once a week). The frequency of vegetable, fruit, and green tea consumption was each estimated according to subject responses and classified as none, 1-2, 3-6 times/week, or every day for vegetables and fruits, and none, 1-6 times/week, or every day for green tea.

Statistical Analysis

Normality was assessed for continuous variables. The Student t test or the Mann-Whitney U test was used to analyze differences in continuous variables by sex. Simple and multiple logistic regression analyses were performed to calculate odds ratios (ORs) of predictor variables for cognitive impairment (MMSE score <24). Continuous variables were divided into quintiles for OR comparisons, and p for trend was calculated by logistic regression analysis. SAS statistical package (release 9.4, Cary, N.C., USA) was used for all statistical analyses. A p value <0.05 was considered statistically significant.

Statement of Ethics

Written informed consent was obtained from all subjects. The protocol of PROST was approved by the Ethics Committee of Niigata University School of Medicine.

Results

The mean subject age was 68.9 years, and the prevalence of cognitive impairment was 21.5%. Subject characteristics by sex are shown in table 1. There were significant differences in age, height, weight, and BMI, but not in MMSE score, by sex.
Table 1

Subject characteristics (n = 1,143)

CharacteristicsMen
Women
p valuea
mean ± SDnmean ± SDn
Age, years68.0±10.763370.0±10.35100.002
Body height, cm164.3±7.3631150.6±6.6503<0.001
Body weight, kg66.2±12.063154.5±11.1501<0.001
BMI24.4±3.463123.9±4.45010.037
MMSE score27b63327b5100.314c

Data are presented as mean ± SD except for MMSE score.

The Student t test was used for MMSE score.

Median.

Mann-Whitney U test.

Sex- and age-adjusted ORs for cognitive impairment according to levels of predictor variables are shown in table 2. Age was a strong predictor of cognitive impairment. Histories of stroke and myocardial infarction, shorter walking time, less drinking, and lower fruit and green tea consumption were associated with cognitive impairment. Although BMI was not significantly associated with cognitive impairment (p for trend = 0.059), the lowest quintile group had a significantly higher OR relative to the reference group (3rd quintile).
Table 2

ORs for cognitive impairment (MMSE score <24) according to levels of predictor variables (n = 1,143)

Predictor variablesSubjects, nCognitive impairment, n prevalence, %)Unadjusted OR (95% CI)Adjusteda OR (95% CI)
Sexp = 0.858p = 0.359
 Women510111 (21.8)1 (ref.)1 (ref.)
 Men633135 (21.3)0.97 (0.73–1.29)1.15 (0.85–1.56)

Agep for trend <0.001p for trend <0.001
 <60 years21010 (4.8)1 (ref.)1 (ref.)
 60–69 years31939 (12.2)2.79 (1.36–5.71)2.83 (1.38–5.82)
 70–79 years441118 (26.8)7.31 (3.74–14.27)7.31 (3.74–14.27)
 ≥80 years17379 (45.7)16.81 (8.33–33.91)16.63 (8.22–33.61)

BMIp for trend = 0.734p for trend = 0.059
 1st quintile (<21.1)22768 (30.0)1.71 (1.11–2.64)1.75 (1.09–2.81)
 2nd quintile (21.1–23.1)22645 (19.9)1.06 (0.67–1.70)1.16 (0.72–1.89)
 3rd quintile (23.2–24.6)22743 (18.9)1 (ref.)1 (ref.)
 4th quintile (24.7–26.7)22743 (18.9)1.00 (0.63–1.60)1.25 (0.76–2.06)
 5th quintile (≥26.8)22547 (20.9)1.13 (0.71–1.79)1.50 (0.92–2.45)
11 missing values

Self-reported history of hypertensionp for trend = 0.686p for trend = 0.065
 No43396 (22.2)1 (ref.)1 (ref.)
 Yes709150 (21.2)0.94 (0.71–1.26)0.75 (0.55–1.02)
1 missing value

Self-reported history of diabetesp for trend = 0.078p for trend = 0.771
 No816187 (22.9)1 (ref.)1 (ref.)
 Yes32559 (18.2)0.75 (0.54–1.03)0.95 (0.67–1.35)
2 missing values

Self-reported history of strokep < 0.001p = 0.005
 No992195 (19.7)1 (ref.)1 (ref.)
 Yes14951 (34.2)2.13 (1.47–3.09)1.80 (1.20–2.71)
2 missing values

Self-reported history of myocardial infarctionp = 0.002p = 0.032
 No1,089225 (20.7)1 (ref.)1 (ref.)
 Yes5321 (39.6)2.52 (1.43–4.45)1.97 (1.06–3.66)
1 missing value

Systolic blood pressurep for trend = 0.840p for trend = 0.362
 1st quintile (<117 mm Hg)20750 (24.2)1 (ref.)1 (ref.)
 2nd quintile (117–127 mm Hg)23652 (22.0)0.93 (0.60–1.44)0.96 (0.59–1.54)
 3rd quintile (128–139 mm Hg)23542 (17.9)0.72 (0.45–1.13)0.70 (0.43–1.15)
 4th quintile (140–150 mm Hg)22350 (22.4)0.95 (0.61–1.48)0.92 (0.57–1.48)
 5th quintile (≥151 mm Hg)23051 (22.2)0.94 (0.60–1.46)0.79 (0.49–1.27)
12 missing values

Diastolic blood pressurep for trend = 0.011p for trend = 0.755
 1st quintile (<63 mm Hg)20559 (28.8)1 (ref.)1 (ref.)
 2nd quintile (63–69 mm Hg)23650 (21.2)0.70 (0.46–1.08)0.89 (0.55–1.42)
 3rd quintile (70–76 mm Hg)23454 (23.1)0.79 (0.51–1.20)1.11 (0.70–1.77)
 4th quintile (77–84 mm Hg)22440 (17.9)0.57 (0.36–0.90)0.84 (0.51–1.39)
 5th quintile (≥85 mm Hg)23242 (18.1)0.58 (0.37–0.91)1.03 (0.61–1.74)
12 missing values
Leisure-time physical activityp for trend = 0.478p for trend = 0.500
None680156 (22.9)1.03 (0.71–1.49)1.04 (0.70–1.53)
 1–2 times/week12320 (16.3)0.67 (0.38–1.20)0.72 (0.39–1.33)
 3–4 times/week7310 (13.7)0.55 (0.26–1.15)0.54 (0.25–1.18)
 ≥5 times/week21448 (22.4)1 (ref.)1 (ref.)
53 missing values

Walking timep for trend = 0.009p for trend = 0.052
 0 min/week3715 (40.5)2.75 (1.39–5.42)2.41 (1.13–5.14)
 1–29 min/week14936 (24.2)1.28 (o. 85–1.94)1.23 (0.79–1.92)
 30–59 min/week13530 (22.2)1.15 (0.74–1.79)1.06 (0.66–1.69)
 ≥60 min/week769153 (19.9)1 (ref.)1 (ref.)
53 missing values

Smokingp = 0.247p = 0.098
 Nonsmoker616135 (21.9)1 (ref.)1 (ref.)
 Past smoker37788 (23.3)1.09 (0.80–1.47)1.40 (0.90–2.17)
 Current smoker14923 (15.4)0.65 (0.40–1.06)1.68 (0.91–3.09)
1 missing value
Alcohol intakep < 0.001p = 0.024
 Nondrinker471129 (27.4)1 (ref.)1 (ref.)
 Chance drinker30461 (20.1)0.67 (0.47–0.94)0.73 (0.50–1.09)
 Drinker at least once/week36756 (15.3)0.48 (0.34–0.68)0.66 (0.42–1.02)
1 missing value
Vegetable consumptionp for trend = 0.100p for trend =0.616
 None182 (11.1)0.44 (0.10–1.91)0.76 (0.16–3.66)
 1–2 times/week397 (18.0)0.76 (0.33–1.75)1.54 (0.62–3.83)
 3–6 times/week527 (13.5)0.54 (0.24–1.22)1.26 (0.52–30.5)
 Every day1,033230 (22.3)1 (ref.)1 (ref.)
1 missing value

Fruit consumptionp for trend = 0.757p for trend = 0.001
 None12029 (24.2)1.10 (0.70–1.75)2.24 (1.31–3.81)
 1–2 times/week20748 (23.2)1.04 (0.72–1.52)1.59 (1.04–2.43)
 3–6 times/week23138 (16.5)0.68 (0.46–1.01)0.86 (0.56–1.32)
 Every day584131 (22.4)1 (ref.)1 (ref.)
1 missing value

Green tea consumptionp for trend = 0.034p for trend = 0.007
 None539133 (24.7)1 (ref.)1 (ref.)
 1–6 times/week13421 (15.7)0.57 (0.34–0.94)0.72 (0.42–1.24)
 Every day46790 (19.3)0.73 (0.54–0.99)0.65 (0.47–0.89)
3 missing values

Adjusted for age and sex (except for the variables sex and age); sex was adjusted for age, and age was adjusted for sex.

To determine independent factors associated with cognitive impairment, multiple logistic regression analysis was performed for candidate predictor variables with statistical significance (table 2), including BMI, histories of stroke and myocardial infarction, walking time, drinking habit, fruit consumption, and green tea consumption. Since the association between BMI quintiles and cognitive impairment was U-shaped (table 2), the analysis was performed with BMI as a discrete variable: 1 = BMI 23.2-24.6 (3rd quintile); 2 = BMI 21.1-23.1 (2nd quintile) and BMI 24.7-26.7 (4th quintile), and 3 = BMI <21.1 (1st quintile) and BMI ≥26.8 (5th quintile). Age, BMI (discrete), histories of stroke and myocardial infarction, and consumption of fruit and green tea were found to be independent predictors of cognitive impairment (table 3). The prevalence of cognitive impairment was much higher in the ≥80-year-old age group (45.7%) than in the other groups, and thus, we conducted a subgroup analysis in the <80- and ≥80-year-old age groups (n = 970 and n = 173, respectively). Age (OR 1.08, 95% CI 0.96-1.21, p < 0.001), history of stroke (OR 1.93, 95% CI 1.19-3.13, p = 0.007), and fruit consumption (OR 0.86, 95% CI 0.68-0.97, p = 0.022) were significant predictors in the <80-year-old age group.
Table 3

Results of multiple logistic regression analysis with cognitive impairment (MMSE score <24) as an outcome (n = 1,143)

Predictor variablesaAdjusted OR (95% CI)p value
Age (years)1.11 (1.08–1.13)<0.001
Body mass indexa1.39 (1.12–1.72)0.003
History of stroke (0 = absent; 1 = present)1.88 (1.24–2.85)0.003
History of myocardial infarction (0 = absent; 1 = present)1.95 (1.04–3.66)0.038
Walking time (0 = none; 1 = 1–29; 2 = 30–59; 4 = ≥60 min/week)0.87 (0.73–1.04)0.132
Alcohol intake (0 = nondrinker; 1 = chance drinker; 3 = drinker)0.86 (0.70–1.04)0.119
Fruit consumption (0 = none; 1 = 1–2; 2 = 3–6; 3 = 7 times/week)0.82 (0.70–0.96)0.012
Green tea consumption (0 = none; 1 = 1–6; 2 = 7 times/week)0.83 (0.70–0.98)0.032

All variables are included in the multivariate model.

BMI is categorized as 1 = 23.2–24.6 (3rd quintile); 2 = 21.1–23.1 (2nd quintile) and 24.7–26.7 (4th quintile), and 3 = <21.1 (1st quintile) and ≥26.8 (5th quintile) given the U-shaped association between BMI and cognitive impairment as shown in table 2.

Discussion

The present study showed that age, BMI, self-reported history of cerebrovascular and cardiovascular diseases, and consumption of fruits and green tea were independently associated with the prevalence of cognitive impairment as assessed by the MMSE. In this study, a low BMI was significantly associated with a high prevalence of cognitive impairment. The association between BMI and cognitive impairment has been somewhat contradictory in the literature. A systematic review by Gorospe and Dave [16] found a high BMI to be a risk factor for dementia. Being overweight, a characteristic feature of metabolic syndrome, is associated with insulin resistance and hypertension, both of which are risk factors for cognitive impairment and dementia [17]. Recent reports suggest that the relationship between BMI and cognition is dependent on age (e.g. midlife vs. late life) [18,19]. Most epidemiological studies [19] have found obesity in midlife to be a risk factor for the development of dementia, whereas a high BMI in late life is a protective factor [19]. According to our data stratified by age groups (table 4), the lowest-BMI group in the older-age group (≥70 years of age) is at high risk of developing cognitive impairment (adjusted OR 2.19), which is in line with the results of previous studies targeting older individuals [19].
Table 4

ORs for cognitive impairment (MMSE score <24) according to levels of BMI stratified by age groups

Predictor variablesSubjects, nCognitive impairment, n (prevalence, %)Unadjusted OR (95% CI)Adjusteda OR (95% CI)
BMI; ≤69 years of age (n = 523)
 <21.1908 (8.9)0.71 (0.27–1.89)0.76 (0.30–2.09)
 21.1–23.11059 (8.6)0.73 (0.28–1.89)0.70 (0.27–1.83)
 23.2–24.68810 (11.4)1 (ref.)1 (ref.)
 24.7–26.71148 (7.0)0.59 (0.22–1.56)0.61 (0.23–1.64)
 ≥26.812614 (11.1)0.98 (0.41–2.31)1.06 (0.44–2.55)
BMI; ≥70 years of age (n = 609)
 <21.113760 (43.8)2.35 (1.41–3.93)2.19 (1.27–3.78)
 21.1–23.112136 (29.8)1.36 (0.78–2.36)1.36 (0.77–2.41)
 23.2–24.613933 (23.7)1 (ref.)1 (ref.)
 24.7–26.711335 (31.0)1.44 (0.83–2.52)1.61 (0.90–2.88)
 ≥26.89933 (33.3)1.62 (0.91–2.85)1.67 (0.93–3.02)

Adjusted for age and sex.

According to a meta-analysis by Anstey et al. [18], a U-shaped relationship was found between midlife BMI and later risk of dementia, i.e. both underweight and overweight individuals are at risk. Moreover, a recent large cohort study showed that underweight individuals are at an increased risk of dementia in all age groups [20]. Our findings are consistent with these reports in that the observed association was nearly U-shaped, although risk in the 5th quintile of BMI was marginal. Taken together, a low BMI appears to be a risk factor for cognitive impairment. It remains unclear why a lower BMI is associated with a higher prevalence of cognitive impairment, but this could be related to low levels of dementia-related molecules, such as leptin and adiponectin, which are protective of cognitive function [19]. Moreover, a lower BMI is associated with in vivo biomarkers of cerebral amyloid and tau, suggesting that neuropathologic changes may occur in areas including the hypothalamus that play regulatory roles in energy metabolism and food intake [21]. It should be noted, however, that there may be a reverse causal relationship, i.e. changes in eating habits of patients with cognitive impairment (e.g. appetite loss) might have led to a low BMI. In the present study, lower fruit consumption was associated with a higher prevalence of cognitive impairment. Although limited epidemiological evidence exists regarding fruit consumption [22,23], associations between greater fruit and vegetable intake and better cognitive performance have been suggested [24,25]. High levels of antioxidants and/or macronutrients from fruits and vegetables reportedly have favorable effects on cognitive function [22]. However, the present study did not detect an association between vegetable consumption and the prevalence of cognitive impairment. This may be due to subjects' responses to the question of vegetable consumption being clustered in the ‘every day’ group. Green tea consumption was also a protective factor against cognitive impairment. Consistent with this, previous cross-sectional [26] and longitudinal [6] studies also reported that consumption of green tea, but not black tea or coffee, protects against cognitive impairment, suggesting that the effects of green tea consumption may be independent of caffeine intake, which is a possible factor for improved cognitive function [3]. Since green tea is widely consumed in Japan, further studies to accumulate evidence are warranted. In agreement with our study, recent review articles showed with sufficient evidence that cognitively stimulating activities, including physical and social activities, are modifiable protective factors [3,27], and that moderate alcohol consumption may also be protective against cognitive impairment [27]. However, conflicting results have been reported on the putative protective role of healthy dietary habits and other lifestyle factors [3,27]. Further well-designed longitudinal studies are needed, especially in Asian populations. As described in the Subjects section, Sado is considered rural in comparison to urban cities such as Niigata City in Japan. The rural aspect of the study location is also characterized by the fact that Sado Island is within uneasy access of mainland Japan. Although the way of living is not different from that on the mainland, findings of the present study may not be generalizable to urban populations. This study has several limitations. First, our subjects were outpatients of a general hospital and may not represent the general population of the same age group. In addition, outpatients have various health problems, which may have confounded predictor-outcome associations in this study. Second, we did not assess subject education level, an important factor associated with cognitive impairment [3]. This may also have confounded the observed associations. Third, self-reported variables are prone to misclassification bias due, in part, to errors of recall. Finally, our study used a cross-sectional design that does not necessarily imply causal relationships and did not assess all modifiable factors associated with cognitive impairment. Further studies will be needed to confirm our results. In conclusion, the present study demonstrated that some modifiable factors, such as low BMI, low fruit consumption, and low green tea consumption, as well as a history of vascular disease, are associated with a high prevalence of cognitive impairment in a Japanese population. Longitudinal studies should be performed to confirm these findings.

Disclosure Statement

The authors report no conflicts of interest.
  23 in total

1.  The validity of the MMSE and SMQ as screening tests for dementia in the elderly general population-- a study of one rural community in Japan.

Authors:  N Maki; M Ikeda; K Hokoishi; A Nebu; K Komori; N Hirono; H Tanabe
Journal:  Dement Geriatr Cogn Disord       Date:  2000 Jul-Aug       Impact factor: 2.959

2.  Long-term care insurance comes to Japan.

Authors:  J C Campbell; N Ikegami
Journal:  Health Aff (Millwood)       Date:  2000 May-Jun       Impact factor: 6.301

Review 3.  The risk of dementia with increased body mass index.

Authors:  Emmanuel C Gorospe; Jatin K Dave
Journal:  Age Ageing       Date:  2006-11-23       Impact factor: 10.668

Review 4.  Modifiable lifestyle factors in dementia: a systematic review of longitudinal observational cohort studies.

Authors:  Luigi Yuri Di Marco; Alberto Marzo; Miguel Muñoz-Ruiz; M Arfan Ikram; Miia Kivipelto; Daniel Ruefenacht; Annalena Venneri; Hilkka Soininen; Isabel Wanke; Yiannis A Ventikos; Alejandro F Frangi
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 5.  Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.

Authors:  K J Anstey; N Cherbuin; M Budge; J Young
Journal:  Obes Rev       Date:  2011-02-23       Impact factor: 9.213

6.  BMI and risk of dementia in two million people over two decades: a retrospective cohort study.

Authors:  Nawab Qizilbash; John Gregson; Michelle E Johnson; Neil Pearce; Ian Douglas; Kevin Wing; Stephen J W Evans; Stuart J Pocock
Journal:  Lancet Diabetes Endocrinol       Date:  2015-04-09       Impact factor: 32.069

7.  Cognitive function in the prefrailty and frailty syndrome.

Authors:  Deirdre A Robertson; George M Savva; Robert F Coen; Rose-Anne Kenny
Journal:  J Am Geriatr Soc       Date:  2014-11-04       Impact factor: 5.562

Review 8.  Fruits, vegetables, 100% juices, and cognitive function.

Authors:  Daniel J Lamport; Caroline Saunders; Laurie T Butler; Jeremy Pe Spencer
Journal:  Nutr Rev       Date:  2014-11-14       Impact factor: 7.110

Review 9.  Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis.

Authors:  May A Beydoun; Hind A Beydoun; Alyssa A Gamaldo; Alison Teel; Alan B Zonderman; Youfa Wang
Journal:  BMC Public Health       Date:  2014-06-24       Impact factor: 3.295

10.  Elevated C-Reactive Protein Is Associated with Cognitive Decline in Outpatients of a General Hospital: The Project in Sado for Total Health (PROST).

Authors:  Yumi Watanabe; Kaori Kitamura; Kazutoshi Nakamura; Kazuhiro Sanpei; Minako Wakasugi; Akio Yokoseki; Osamu Onodera; Takeshi Ikeuchi; Ryozo Kuwano; Takeshi Momotsu; Ichiei Narita; Naoto Endo
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-01-19
View more
  11 in total

1.  A decrease in the number and incidence of osteoporotic hip fractures among elderly individuals in Niigata, Japan, from 2010 to 2015.

Authors:  Norio Imai; Naoto Endo; Yugo Shobugawa; Shinya Ibuchi; Hayato Suzuki; Dai Miyasaka; Mayumi Sakuma
Journal:  J Bone Miner Metab       Date:  2017-09-07       Impact factor: 2.626

2.  Association between tea consumption and risk of cognitive disorders: A dose-response meta-analysis of observational studies.

Authors:  Xueying Liu; Xiaoyuan Du; Guanying Han; Wenyuan Gao
Journal:  Oncotarget       Date:  2017-06-27

3.  Blood brain barrier permeability of (-)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice.

Authors:  Monira Pervin; Keiko Unno; Aimi Nakagawa; Yuu Takahashi; Kazuaki Iguchi; Hiroyuki Yamamoto; Minoru Hoshino; Aya Hara; Akiko Takagaki; Fumio Nanjo; Akira Minami; Shinjiro Imai; Yoriyuki Nakamura
Journal:  Biochem Biophys Rep       Date:  2017-01-05

Review 4.  Association of Tea Consumption with Risk of Alzheimer's Disease and Anti-Beta-Amyloid Effects of Tea.

Authors:  Curt Anthony Polito; Zhuo-Yu Cai; Yun-Long Shi; Xu-Min Li; Rui Yang; Meng Shi; Qing-Sheng Li; Shi-Cheng Ma; Li-Ping Xiang; Kai-Rong Wang; Jian-Hui Ye; Jian-Liang Lu; Xin-Qiang Zheng; Yue-Rong Liang
Journal:  Nutrients       Date:  2018-05-22       Impact factor: 5.717

Review 5.  Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases.

Authors:  Monira Pervin; Keiko Unno; Tomokazu Ohishi; Hiroki Tanabe; Noriyuki Miyoshi; Yoriyuki Nakamura
Journal:  Molecules       Date:  2018-05-29       Impact factor: 4.411

6.  Molecular Network Analysis of the Urinary Proteome of Alzheimer's Disease Patients.

Authors:  Yumi Watanabe; Yoshitoshi Hirao; Kensaku Kasuga; Takayoshi Tokutake; Yuka Semizu; Kaori Kitamura; Takeshi Ikeuchi; Kazutoshi Nakamura; Tadashi Yamamoto
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2019-02-08

7.  The Association Between Eating Green Vegetables Every Day And Mild Cognitive Impairment: A Community-Based Cross-Sectional Study In Shanghai.

Authors:  Wei Li; Lin Sun; Ling Yue; Guanjun Li; Shifu Xiao
Journal:  Neuropsychiatr Dis Treat       Date:  2019-11-18       Impact factor: 2.570

Review 8.  Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases.

Authors:  Ryuuta Fukutomi; Tomokazu Ohishi; Yu Koyama; Monira Pervin; Yoriyuki Nakamura; Mamoru Isemura
Journal:  Molecules       Date:  2021-01-14       Impact factor: 4.411

9.  Weight loss from 20 years of age is associated with cognitive impairment in middle-aged and elderly individuals.

Authors:  Kaori Kitamura; Yumi Watanabe; Kazutoshi Nakamura; Akemi Takahashi; Ribeka Takachi; Rieko Oshiki; Ryosaku Kobayashi; Toshiko Saito; Shoichiro Tsugane; Ayako Sasaki
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

Review 10.  Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies.

Authors:  Shogo Nakano; Shin-Ichi Megro; Tadashi Hase; Takuji Suzuki; Mamoru Isemura; Yoriyuki Nakamura; Sohei Ito
Journal:  Molecules       Date:  2018-08-13       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.